Danvers, MA 7/9/09—Cell Signaling Technology (CST), a manufacturer of antibodies and reagent products, has acquired all the shares of Netherlands-based BIOKÉ BV, its distributor for the Benelux region. Renamed Cell Signaling Technology Europe, the business will begin filling orders effective January 1, 2010. “This acquisition will permit CST to better support its European customers and […]

San Diego, CA 7/1/09—Illumina has revised its forecast for the second quarter and year-end. The company now expects second-quarter revenues of approximately $161 million, compared to guidance of $168–$173 million (see IBO 5/15/09). Full-year revenues are now estimated to be $690–$720 million. Citing a sequential quarterly decline in array revenue for the change, Illumina highlighted […]

The growing volume and complexity of genomic research requires higher-throughput, higher-density techniques that can simultaneously capture multiple data points with greater sensitivity at a lower cost per point. Rare variant research, validation studies and biomarker discovery are among the applications that will directly benefit. Such advancements are also applicable to the development and application of […]